Skip to content

DOKTER BART GORDTS

Active
Private limited companyfounded 199630 years activeColettijnenhof 23, 8000 Brugge, BelgiumKBO/BCE: BE 0458.917.985
Summary

DOKTER BART GORDTS has been active since 1996 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €100,154. Equity is growing by ~6% per year across the filed fiscal years. Its solvency ranks better than 95% of 608 sector peers (NACE 72, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101
#8 oldest company in West Flanders, Research and development sector1 site
Size
€1.2mtotal assets 2025
Equity
€1.2m
Profit
€100,154
Turnover not published (abridged schema)
Financial health
95 Excellent Checked score 2025
Bankruptcy probability, 12 months
< 0.1%
Structure
Accounts 24 days early0 of 6 deeds read
Why 95+ Equity €1.2m (99.6% of total assets)+ Size: total assets €1.2m+ Liquidity: current ratio 277.31, cash €133,170+ Figures for FY 2025 (filed 10-01-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 99.6% of total assets
Liquidity 64+1
short-term debt 0.4% · cash 11.2%
Profitability 79+5
return on assets 8.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (934 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024highest value 02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: 0.1%▲ +0.1 percentage points vs 12-2025 02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit up to €110,000 at 30 days acceptable
short-term debt: 0.4% and cash: 11.2% of total assets, and 0.4% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 83% on solvency, 53% on liquidity, 55% on profitability and 62% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk○neutral
lowers risk · Equity €1.2m (99.6% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €1.2m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 277.31, cash €133,170
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 10-01-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 07-01-2026, 24 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
24 days early
2024
25 days early
2023
16 days early
2022
14 days early
2021
4 days early
2020
2 days early
2019
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 15 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 15 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-06-2026 close07-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Liquidity times 19current ratio 832.24

Key points

  • Positive: Result rose in 2025from €49,074 to €100,154 ▲ 104% View
  • Positive: Among the best 5% on solvencysector median 60.6% · 608 companies 99.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €100,154 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.2m
Profit
€100,154
Solvency
99.6%
Total assets▲ 9.5%
Net result
20192025
Go to Financials

Timeline

Events
16
Since
2017
Next accounts
by 31-01-2027
  1. 15-01-2024Annual accounts filed
  2. 30-06-2023Liquidity triples
  3. 30-06-2023Equity above €1m
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
01-10-1996
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.